Cadence Design Systems (CDNS) Tops Q1 EPS by 2c; Guides Q2, FY12
Get Alerts CDNS Hot Sheet
Price: $323.77 --0%
Financial Fact:
Restructuring and other charges (credits): 101K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Financial Fact:
Restructuring and other charges (credits): 101K
Today's EPS Names:
OTLK, EGRX, MOVE, More
Join SI Premium – FREE
Cadence Design Systems (NASDAQ: CDNS) reported Q1 EPS of $0.17, $0.02 better than the analyst estimate of $0.15. Revenue for the quarter came in at $316 million versus the consensus estimate of $309.7 million.
Cadence Design Systems sees Q2 2012 EPS of $0.17-$0.18, versus the consensus of $0.18. Cadence Design Systems sees Q2 2012 revenue of $315-$325 million, versus the consensus of $313.5 million.
Cadence Design Systems sees FY2012 EPS of $0.66-$0.70, versus the consensus of $0.68. Cadence Design Systems sees FY2012 revenue of $1.27-$1.3 billion, versus the consensus of $1.27 billion.
For earnings history and earnings-related data on Cadence Design Systems (CDNS) click here.
Cadence Design Systems sees Q2 2012 EPS of $0.17-$0.18, versus the consensus of $0.18. Cadence Design Systems sees Q2 2012 revenue of $315-$325 million, versus the consensus of $313.5 million.
Cadence Design Systems sees FY2012 EPS of $0.66-$0.70, versus the consensus of $0.68. Cadence Design Systems sees FY2012 revenue of $1.27-$1.3 billion, versus the consensus of $1.27 billion.
For earnings history and earnings-related data on Cadence Design Systems (CDNS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share